Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis : Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
CNS & neurological disorders drug targets - 16(2017), 9 vom: 28., Seite 971-973 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Padilla Del Campo, Carmen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 25.03.2019 Date Revised 25.03.2019 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2174/1871527317666180104110111 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM279631065 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279631065 | ||
| 003 | DE-627 | ||
| 005 | 20231225023426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1871527317666180104110111 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0932.xml |
| 035 | |a (DE-627)NLM279631065 | ||
| 035 | |a (NLM)29299991 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Padilla Del Campo, Carmen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis |b Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2019 | ||
| 500 | |a Date Revised 25.03.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Tunez, Isaac |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS & neurological disorders drug targets |d 2006 |g 16(2017), 9 vom: 28., Seite 971-973 |w (DE-627)NLM161975518 |x 1996-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2017 |g number:9 |g day:28 |g pages:971-973 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871527317666180104110111 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2017 |e 9 |b 28 |h 971-973 | ||